Quest Diagnostics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -35.17. In total, the insiders bought 331.03K and sold 124.91K DGX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-35.17 |
| ● Buy | 331.03K shares |
| ● Sell | 124.91K shares |
|
55% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 04, 2026 Buy |
Kuppusamy Karthik SVP, Clinical Solutions |
3 320 Value: $424.0K |
||
|
Jun 04, 2026 Buy |
Kuppusamy Karthik SVP, Clinical Solutions |
4 827 Value: $588.0K |
||
|
Jun 04, 2026 Buy |
Kuppusamy Karthik SVP, Clinical Solutions |
3 320 Value: $424.0K |
||
|
Jun 04, 2026 Buy |
Kuppusamy Karthik SVP, Clinical Solutions |
4 827 Value: $588.0K |
||
|
Jun 04, 2026 Sell |
Kuppusamy Karthik SVP, Clinical Solutions |
8 147 Value: $1.63M |
||
|
Jun 01, 2026 Sell |
Davis J. E. CEO And President |
10 000 Value: $1.94M |
||
|
May 20, 2026 Buy |
Morrison Denise M Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Pfeiffer Gary M Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Diaz Luis Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Main Timothy L Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Wentworth Timothy C Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Doi Tracey Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Gregg Vicky B Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Carter Robert B Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Lassiter Wright Iii Director |
1 142 Value: $221.3K |
||
|
May 20, 2026 Buy |
Ring Timothy M Director |
1 142 Value: $221.3K |
||
|
Apr 20, 2026 Buy |
Gregg Vicky B Director |
68 Value: $13.2K |
||
|
Apr 20, 2026 Buy |
Plewman Patrick SVP For Diagnostic Services |
49 Value: $10K |
||
|
Apr 20, 2026 Buy |
Samad Sam Executive Vice President & CFO |
108 Value: $21.0K |
||
|
Apr 20, 2026 Buy |
Carter Robert B Director |
7 Value: $1K |
||
|
Apr 20, 2026 Buy |
Delaney Mark E SVP & Chief Commercial Officer |
37 Value: $7K |
||
|
Apr 20, 2026 Buy |
Kuppusamy Karthik SVP, Clinical Solutions |
39 Value: $8K |
||
|
Apr 20, 2026 Buy |
Lassiter Wright Iii Director |
6 Value: $1K |
||
|
Apr 01, 2026 Buy |
Wentworth Timothy C Director |
198 Value: $39.1K |
||
|
Mar 09, 2026 Buy |
Wentworth Timothy C Director |
215 Value: $43.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
Sign In
Buy DGX